SIU 2017 Prostate Cancer - Results from #40

Viewing 41-56 of 56 articles

SIU 2017: Prostate Cancer Can Be Detected Even in Patients with Decreased PSA after Antibiotic Therapy

SIU 2017: Automatic Grading of Prostate Cancer using the Gleason Grading Groups

SIU 2017: Presence of Only Clinical Stage T2c Is Not Sufficient to be Classified as High Risk Prostate Cancer

SIU 2017: GA-PSMA-PET/CT VS. Choline-PET/CT in Malignant Prostate Cancer - A Systematic Review

SIU 2017: Comparison of 68Ga-PSMA-PETCT with Multiparametric MRI for Staging High Risk Prostate Cancer

SIU 2017: Comparison of Multiparametric and Biparametric MRI Cognitive Targeted First Round Prostate Biopsy for Patients with a PSA Level under 10 Ng/Ml

SIU 2017: Impact of Canadian Task Force on Preventative Health Care Recommendation Against PSA Screening on Radical Prostatectomy Results

SIU 2017: Novel Classification of Gleason 7 Prostate Cancer According to the Discrepancy between Biopsy and Final Gleason Score after Radical Prostatectomy

SIU 2017: Local Treatment for Metastatic Prostate Cancer

SIU 2017: Radiogenomics, MRI & Prostate Cancer Imaging

SIU 2017: Therapy for Prostate Cancer - Who and How?

SIU 2017: Advanced Risk Modeling for Prostate Cancer

SIU 2017: DNA Repair Mutations and Prostate Cancer

SIU 2017: The USPSTF Screening Review - What Are the Implications?

SIU 2017: Active Surveillance: Biopsy vs MRI for Follow Up

SIU 2017: Prostate Cancer Stem Cells

1
2
3

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.